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Abstract
Background: The existence of publicly-accessible datasets comprised a significant opportunity for
health services research to evolve into a science that supports health policy making and evaluation,
proper inter- and intra-organizational decisions and optimal clinical interventions. This paper
investigated the role of publicly-accessible datasets in the enhancement of health care systems in
the developed world and highlighted the importance of their wide existence and use in the Middle
East and North Africa (MENA) region.
Discussion: A search was conducted to explore the availability of publicly-accessible datasets in
the MENA region. Although datasets were found in most countries in the region, those were
limited in terms of their relevance, quality and public-accessibility. With rare exceptions, publicly-
accessible datasets - as present in the developed world - were absent. Based on this, we proposed
a gradual approach and a set of recommendations to promote the development and use of publicly-
accessible datasets in the region. These recommendations target potential actions by governments,
researchers, policy makers and international organizations.
Summary: We argue that the limited number of publicly-accessible datasets in the MENA region
represents a lost opportunity for the evidence-based advancement of health systems in the region.
The availability and use of publicly-accessible datasets would encourage policy makers in this region
to base their decisions on solid representative data and not on estimates or small-scale studies;
researchers would be able to exercise their expertise in a meaningful manner to both, policy
makers and the public. The population of the MENA countries would exercise the right to benefit
from locally- or regionally-based studies, versus imported and in 'best cases' customized ones.
Furthermore, on a macro scale, the availability of regionally comparable publicly-accessible datasets
would allow for the exploration of regional variations and benchmarking studies.
Background
Improving the performance and functioning of health
care systems in any country is greatly enhanced by the
existence of publically-accessible datasets. These datasets,
mostly collected and hosted by governmental agencies or
private organizations, are accessible (as data files) either
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directly from the data keepers or through a review process
organized by a host agency (e.g university, research center,
etc.). They provide an opportunity for researchers, policy
makers and practitioners to easily access relevant informa-
tion to answer key questions such as assessing the optimal
health care policies and its effects; the health status of the
population; the amount of money that is being spent on
a particular intervention or sector; the number of health
workers needed for the delivery of health services and the
quality of care delivered among others.
In many developed countries, the availability of publicly-
accessible databases has modified the field of public
health research in general, and health services research in
particular, in innumerable ways. Historically, many enti-
ties (e.g. governmental agencies, health care providers,
insurance companies, etc.) systematically collected/gener-
ated data to serve various functions (e.g. billing and col-
lection, intra-organizational quality measurement and
improvement, human resources management, strategic
planning, etc.). However, access to these databases was
mostly limited to the entity itself and was not made avail-
able to external parties. The beginning of the granting of
public accessibility to databases trend can be traced to cer-
tain types of datasets such as clinical registries, delivery/
utilization and financial information, as well as popula-
tion surveys. In each of these types, there were different
purposes for the existence of the various publicly-accessi-
ble datasets. Currently, the number and type of publicly-
accessible datasets related to health services research are
too abundant to take stock of. Furthermore, the recent
trend of merging data from various countries (e.g. Organ-
ization of Economic Cooperation and Development
(OECD), registries, etc.) comprises a unique opportunity
for health services researchers to consider performing
comparative investigations.
In the Middle East and Northern Africa (MENA) region, as
is the case in other developing regions of the world, efforts
of governmental and non-governmental agencies to
answer many health care services-related questions are
often hindered by an assortment of challenges, many of
which relate to data sources - scarcity, restrictions on
access, incomparability, outdated, etc. These challenges
often lead to governments and health analysts relying on
inaccurate estimations and forecasts in assessing the per-
formance and planning the future of their health care sys-
tems. Inaccurate numbers also shift decision making in
the health care field from the realm of health policy to
that of politics.
To initiate the process of creating and providing access to
datasets, certain preconditions have to exist. These
include, but are not limited to, political will, administra-
tive capabilities, stakeholders' buy-ins and demonstrated
utility (or good argument for it). Ultimately, the advocacy
for the creation and effective utilization of publicly-acces-
sible data repositories should be based on the perceived
utility of such datasets in supporting health systems plan-
ning and policy making, as well as evaluating the current
health care structure and its efficiency. The bullet points
below outline some of the potential benefits that could be
reaped from creating publically-accessible datasets.
The potential benefits from the creation of 
publicly-accessible databases
• Ensuring the comparability and quality requirements
of various data sources by creating and coordinating
health information standards [1]
￿ Allowing the analysis of past and forecasting future
trends through the creating of longitudinal databases
on health spending, health delivery and health human
resource [2].
￿ Supporting evidence based health planning and deci-
sion making by providing accurate information and
analyses on the performance of health care systems
[3].
￿ Building capacity in evidence based research and pol-
icy analysis by granting researchers access to data
sources (with strong protection of privacy and confi-
dentiality of individual information) that could help
them answer their research questions [4].
￿ Advancing medical practice by enhancing the under-
standing on the patterns of health and disease in the
population through the creation of large longitudinal
datasets of patient records [5].
￿ Allowing linkage of datasets from different sectors to
analyze broader determinants of health [5].
￿ Identifying and promoting national health indicators.
(mortality, morbidity, per capita health spending,
etc.) and ensuring regional/international comparabil-
ity [6].
￿ Enhancing transparency and accountability in health
care systems through a number of knowledge transla-
tion activities (e.g. publications, analyses, educational
sessions and conferences) to a variety of stakeholders
including patients [7].
￿ Allowing the establishment of benchmarks and identifica-
tion of best practices in the financing, organization and
delivery of health programs [8]; [9].
The advocacy for such utility can actually be supported
through evidence. As a start, significant advancement in
evidence-based clinical practice resulted from researchBMC Health Services Research 2009, 9:197 http://www.biomedcentral.com/1472-6963/9/197
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studies utilizing publicly-accessible datasets, especially
clinical registries. Of the many examples in which the use
of publicly-accessible datasets advanced evidence-based
clinical practice, two are noteworthy: the use of "Statins"
("Statin" is a class of hypolipidemic drugs used to lower
cholesterol levels in people with or at risk of cardiovascu-
lar disease) in the prevention of cardiovascular and other
diseases [10-14] and the potential protective effects of
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) against
cancer and other chronic diseases [15-19].
In addition, analysis of large publicly-accessible datasets
could also help shape, inform and evaluate the organiza-
tion, delivery and financing of health services in a health
care system. An infamous example is the RAND Health
Insurance Experiment (HIE) which presented a persuasive
evidence that cost sharing (compared to free health serv-
ices) reduced the use of health services without necessarily
reducing the quality of care provided or causing adverse
effect on consumers' health. The experiment itself is an
example of the importance of the availability of public
datasets. Another example on the central role datasets are
playing in shaping health care is NHS's publicly accessible
Secondary Uses Services (SUS) dataset which is poised in
2009 to become NHS's single, authoritative and compre-
hensive repository of high quality data on all aspects of
patient care. In recent years, many professional organiza-
tions have focused considerable effort on advocating for
the use of decision making based on research generated
from representative and/or valid datasets. These organiza-
tions, e.g. International Society for Pharmacoeconomics
and Outcomes Research and AcademyHealth, convened
task forces that advocate for such an approach to decision
making [20].
The limited existence and poor quality of publicly-accessi-
ble datasets in developing countries, especially the MENA
region, is a great hindrance to the advancement of evi-
dence-based decision making. In fact, there is a dearth of
information when it comes to the degree of availability of
such datasets in the Region. In this paper, we aim to pro-
vide a scan of what publicly-accessible datasets are availa-
ble in MENA; we focus on building the case for MENA
countries to adopt a strategy of creating and providing
access to publicly-accessible datasets as a valuable tool in
clinical and policy decision making. Recommendations
are also presented that target potential actions by govern-
ments, researchers, policy makers and international
organizations.
Publicly-accessible datasets in the MENA 
context
Methodological Approach
A four pronged approach was devised in an effort to take
stock of what publicly-accessible datasets are available in
the MENA region. The search was initiated with an online
review of the websites of the regional office of interna-
tional organizations like the World Health Organization,
East Mediterranean Regional Office (WHO-EMRO) in
addition to individual country office websites affiliated
with WHO. The information collected from this review
was supplemented by a review of the websites of the Min-
istries of Health and Social Affairs of the 24 countries of
the MENA region. Compiled information was synthesized
by one of the authors and reviewed through a number of
research meetings by the research team. If the collected
information about any of the MENA countries was
deemed inaccurate and/or insufficient to confirm the
existence and/or public accessibility of datasets, the Min-
istries in respective countries were contacted by email
and/or phone.
Verification of collected information was done through
the triangulation of data from various sources. It was fur-
ther strengthened by the informed opinion of the authors
and experts with considerable work and research experi-
ence in the Region (Figure 1).
Overview of Publicly-accessible Datasets in MENA
Our search revealed that datasets in the MENA region gen-
erally do not exist in an open-access format. Some datasets
are housed in professional organizations (e.g. orders or
syndicates of physicians, nurses) or Ministries, yet is only
available in aggregate format (e.g. reports drafted by
organizations or Ministries) - Table 1. This data can be
compiled into spreadsheets; however, lack of accessibility
remains a major obstacle throughout the region.
Human Resources for Health (HRH) datasets were availa-
ble for all countries in MENA region (with exception of
Cyprus and Western Sahara). Such datasets included abso-
lute numbers and densities of physicians, nurses, mid-
wives, dentists, pharmacists, physiotherapists, medical
assistants, clinical officers, laboratory personnel, radiolo-
gists, environmental and public health workers, commu-
nity health workers, administrative and support staff, and
miscellaneous technicians. It should be noted that many
of the above health professional categories are further
divided into technicians or assistants. However, most
countries did not report all of the above data on an annual
basis, with the exception of Pakistan which had the most
detailed results. The data source for most of these coun-
tries was the HRH observatory for the WHO-EMRO [21].
Other data sources included the ministries of health web-
sites.
Findings of the search revealed that quality of care data is
sparse for countries in the region. The only data available
were from Afghanistan and Iran. Documentation of a bal-
anced score card initiative was found for Afghanistan forBMC Health Services Research 2009, 9:197 http://www.biomedcentral.com/1472-6963/9/197
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2006 and 2007 [22]. As for Iran, the WHO Country Office
has 32 programs which include health management infor-
mation system (HMIS), health policy development,
health system development, and health system research,
among other topics [23] (Table 1).
Health system facilities data was available for some coun-
tries in the region. For example, Bahrain has a detailed
ministry of health (MOH) website which included data
on financial statistics (total government expenditure,
MOH expenditure, share of health expenditure by govern-
ment, and revenues to ministry by fiscal year [1998 to
2007]) [24]. As for the case of Qatar, most of the informa-
tion available on the MOH website included data on
health systems and facilities like hospitals, pharmacies
and health care centers (by geographic location) [25]. The
only information available on health systems in Somalia
included laboratory support - mostly as it relates to Hepa-
titis B and Tuberculosis [26]. Sudan is trying to improve
the health status of its population through the establish-
ment and rehabilitation of health facilities, yet collected
heath information primarily focused on Darfur [27]. As
for the case of Yemen, some information was found on
distribution of health facilities [28].
Similar to the case of quality, information on health
finances statistics was limited to only two countries; Bah-
rain and Lebanon. In Bahrain, the reports of annual statis-
tics dating from 2000 to 2007 included some financial
data (total government expenditure, MOH expenditure,
share of health expenditure by government, and revenues
to ministry by fiscal year [1998 to 2007]) [24]. In Leba-
non, the only information relating to this issue on the
MOH website was the number of granted "visas" for inpa-
tient visits for 2004. According to the Lebanese MOH, a
visa refers to granted approval for hospitalization at the
MOH expense for eligible patients. The Lebanese MOH
has recently compiled a database on clinical utilization
and spending indicators, which include data for many but
not all hospitals. These variables include: total inpatient
cost per hospital, total admissions and days of admission,
total one-day admissions, paid cost per day, repeat diag-
nosis, emergency admissions, ICY admissions, and rates
for specific conditions such as Cataracts, Cardiology, Can-
cer and Chemotherapy. The data can also be used to
derive a relative clinical risk and relative efficiency scores.
However, not all hospitals regularly collect this data
which could be used by the MOH for benchmarking and
performance contracting [29].
In short, despite of the availability of certain types of data
related to health systems in the region, our findings clearly
show that such data is mostly presented in a report format
in addition to not being consistently available across
MENA countries. However, one exception is noteworthy
as our search revealed that the Palestinian Central Bureau
of Statistics provides public access to a number of datasets
based on relatively recent data (e.g. 2007 census). The
datasets available cover a number of health topics and
studies such as access to health services, demographic and
health survey, finance and insurance survey, health pro-
viders and beneficiaries survey, and household health
expenditure survey among many others. All studies and
topics have brochures, a code book and the questionnaire.
It should be noted that the datasets are available for a
small fee for individuals, local institutions and interna-
tional institutions [30].
However, except the success story of the Palestinian Cen-
tral Bureau of Statistics, our overview of dataset availabil-
ity in the MENA region revealed that the solution to the
problem of modest availability of publicly-accessible
datasets should be gradual and start from ensuring availa-
bility to relevance and usefulness (quality), accessibility
and comparability. This stems from the fact that there may
be a wealth of datasets available in the region, yet the rel-
evance and usability of these datasets is dubious in most
instances. When usable datasets are available, they are sel-
dom accessible to researchers and policy makers. Finally,
little is done to ensure regional comparability of available
datasets across the MENA countries. Figure 2 presents a
graphical illustration of how to maximize the utility of
datasets.
Discussion
The existence of publicly-accessible datasets comprised a
significant opportunity for health services research to
evolve into a science that supports health policy making
and evaluation, proper inter- and intra-organizational
decisions and optimal clinical interventions. However,
most of these developments in the discipline occurred in
the US and Europe. Other parts in the World, specifically
the MENA region, did not witness a parallel evolvement in
The methodological approach used to take stock of publically  accessible datasets in the MENA region Figure 1
The methodological approach used to take stock of 
publically accessible datasets in the MENA region.
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Table 1: An overview of dataset availability in the MENA region  
MENA 
Countries
Human 
Resources in 
Health
Health Data Quality Health System 
and facilities
Financial 
Statistics
Middle East Cancer 
Consortium¥
Middle East IVF 
Registry£
1A f g h a n i s t a n ✓✓ ✓
2 Bahrain ✓✓ ✓ ✓ ✓
3C y p r u s ✓✓
4 Djibouti (F) ✓
5E g y p t ✓✓ ✓ ✓
6I r a n ✓✓ ✓
7I r a q ✓✓
8 Jordan ✓✓ ✓ ✓
9K u w a i t ✓✓
10 Lebanon ✓✓ ✓ ✓
11 Libya ✓✓
12 Morocco (F) ✓✓
13 Oman ✓✓
14 Palestine* ✓✓ ✓ ✓
15 Pakistan ✓✓
16 Qatar ✓✓ ✓
17 Saudi Arabia ✓✓ ✓
18 Somalia ✓✓ ✓
19 Sudan ✓✓ ✓
20 Syria ✓✓
21 Tunisia (F) ✓✓ ✓
22 United Arab 
Emirates
✓✓ ✓
23 Western Sahara** ✓
24 Yemen ✓✓ ✓
* Referred to as West Bank and Gaza on some international websites; This is the only MENA country with publicly accessible databases (through the (Palestinian 
Central Bureau of Statistics)
** This is a conflict country
¥ Lebanon is not a member of this consortium, probably since Israel is also a member: http://mecc.cancer.gov/registry.html. They have an 82-page "Manual of 
standards for Cancer Registration" available on: http://mecc.cancer.gov/MECC_Manual_of_Standards.PDF They also have a link to all publications from the registry 
on: http://mecc.cancer.gov/publications.html;
£ No website was found for the In-Vitro Fertilization registry. A report by Ragaa Mansour about the IVF registry was documentedBMC Health Services Research 2009, 9:197 http://www.biomedcentral.com/1472-6963/9/197
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publicly-accessible datasets. Most of the datasets in the
region remain private or have strict guidelines for accessi-
bility and use. As such, this paper is a call for all policy
makers and health services researchers in the region to
actively start lobbying for the public availability and
accessibility of the datasets that would help explore/solve
the many health care issues that plague the region.
For example, clinical registries are an important resource
that countries in the MENA region could tap into to mon-
itor, assess and advance the health of their population.
The uses of registries are many and their potential is out-
standing, especially if MENA region countries were able to
link information collected across different countries. This
would allow the comparison of diseases incidence rates
across regions, populations and countries. In addition, its
linkage with other datasets (e.g. claims) can produce val-
uable evidence for policy planning and identifying cost-
effective treatments. Similarly, longitudinal analysis of
human resource registration databases could help
enhance the understanding of researchers and policy mak-
ers on employment patterns and attrition rate from the
workforce. This would help inform future resource plan-
ning and optimize matching the demand and supply of
health human resources. This is pivotal considering the
global shortage of health human resources, which is
intensified in the MENA region.
Based on this, the MENA region has a prime opportunity
to join the trend of evidence-based decision making. Spe-
cifically, we think the following recommendations com-
prise actionable steps:
￿ Lobbying Ministries of Health (and Social Affairs
where applicable) to take stock of what datasets are
available. In addition, plan and implement strategies
to highlight their existence and methods to access
these datasets
￿ Encouraging of governmental health agencies, spe-
cifically Ministries of Health, to play a central role in
employing - and advocating for - evidence-based pol-
icy making
￿ Advocating for international and regional entities to
act as coordinators for data banks, as well as support
for data building infrastructure projects
￿ Highlighting the role academic institutions and
national statistics bodies can play as independent par-
ties for data collection, storage and analysis
￿ Advising and strengthening of regional efforts to
standardize collected data as much as possible
A Conceptual Illustration of Maximizing the Utility of Datasets Figure 2
A Conceptual Illustration of Maximizing the Utility of Datasets.
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￿ Establishing a higher committee within each country
- as well as regionally - that would identify a minimum
dataset for targeted areas of data collection
￿ Encouraging regional researchers to focus on rele-
vant research topics and highlight the importance of
the findings to policy makers and practitioners
￿ Highlighting regional knowledge exchange around
best practices and comparative studies
It is our belief that such steps would form a concrete foun-
dation for the establishment of a friendly environment for
the creation of publicly-accessible datasets. The start of the
process can/should be modest. For example, taking stock
of the available datasets and exerting an effort to make
what is available, or at least part of it, public (or simplify-
ing the process of gaining access to the raw data).
This paper has limitations that merit consideration. First,
the WHO website has a link to individual country profiles
for all countries, but information is not always complete,
up-to-date or accurate. This data cannot be considered a
registry, but the WHO-SIS documents data on a semi-
annual basis. Second, while the search conducted
included all countries of the MENA and most accessible
data sources, it may not have been comprehensive. In this
regard, it should be acknowledged that not all data
sources in the region are publicly accessible to researchers
or the general public. Some databases, registries and even
reports may require certain organizational privileges.
In conclusion, policy makers in this region should be
ready and willing to base their decisions on solid repre-
sentative data and not on estimates or small-scale studies;
Researchers should be able to exercise their expertise in a
meaningful manner to both, policy makers and the pub-
lic. In addition, researchers have the responsibility to
highlight the utility of evidence-based decision making as
a reason for increasing public accessibility of data. Finally,
the population of the MENA countries has the right to
benefit from locally- or regionally-based studies, versus
imported and in best cases customized ones that have a
direct effect on the clinical care they receive and as the
basis for policies which affect their health care. We
acknowledge that what we are calling for here might be a
paradigm shift for a number of countries in the MENA
region. We do not anticipate change to happen overnight
but suggest a course of action that if taken could bring a
lot of benefit to the region.
Summary
￿ Publicly-accessible datasets represent a catalyst for
the enhancement of health care systems through the
ability to conduct policy- and clinically-relevant
health services research
￿ Our search revealed that although datasets are avail-
able in most Middle East and North African (MENA)
countries, they are limited in terms of quality, accessi-
bility and relevance which hinders the ability to
explore the datasets' full potential
￿ Such finding represents a lost opportunity for the
evidence-based advancement of health systems in the
region
￿ Practical recommendations targeted towards
researchers, policy makers and agencies (public and
private) are presented to make the case for the devel-
opment of relevant, accessible and regionally-compa-
rable datasets
￿ The move towards the wide-spread of publicly-acces-
sible datasets will have to be an incremental process
and will depend upon each of the countries' existing
infrastructure and willingness to incorporate such an
agenda in strategic planning for health
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